James Scott H, Sheffield Jeanne S, Kimberlin David W
Department of Pediatrics, University of Alabama at Birmingham.
University of Texas Southwestern Medical Center, Dallas.
J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1(Suppl 1):S19-23. doi: 10.1093/jpids/piu050.
Infections with herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2), both alpha herpesviruses, are highly prevalent worldwide. Both HSV types commonly cause genital infection, which, when acquired or reactivated during pregnancy, carries with it the risk of transmission to the fetus or neonate. Women who acquire primary or first-episode genital herpes during pregnancy are at greater risk for transmitting the infection than are women with recurrent genital herpes. Because viral infection and reactivation are frequently asymptomatic, many affected women are unaware of their infection and risk of transmission to their infants. Neonatal HSV infection can have devastating long-term consequences, especially when the central nervous system (CNS) is involved. Treatment of affected neonates with intravenous acyclovir has improved outcomes but there is room for further improvement, especially in regard to CNS disease. Working with pregnant women to prevent mother-to-child transmission of HSV is an important component in reducing the overall disease burden of neonatal HSV infections.
单纯疱疹病毒1型(HSV-1)或2型(HSV-2)感染均为甲型疱疹病毒感染,在全球范围内高度流行。这两种HSV类型通常都会引起生殖器感染,在孕期感染或复发时,会有传染给胎儿或新生儿的风险。孕期初次感染或首次发作生殖器疱疹的女性,比复发性生殖器疱疹女性的传染风险更高。由于病毒感染和复发通常没有症状,许多受感染女性并未意识到自己已感染以及有传染给婴儿的风险。新生儿HSV感染可能会产生严重的长期后果,尤其是累及中枢神经系统(CNS)时。静脉注射阿昔洛韦治疗受感染新生儿可改善预后,但仍有进一步改善的空间,尤其是在中枢神经系统疾病方面。与孕妇合作预防HSV母婴传播,是减轻新生儿HSV感染总体疾病负担的重要组成部分。